Aller au contenu

Publications scientifiques

  • article Bérubé M, Lapierre A, Sykes M, Grimshaw J, Turgeon AF, Lauzier F, Taljaard M, Stelfox HT, Witteman H, Berthelot S, Mercier É and Gonthier C, Paquet J, Fowler R, Yanchar N, Haas B, Lessard-Bonaventure P, Archambault P, Gabbe B, Guertin JR, Ouyang Y, Moore L and

    Development and usability testing of a multifaceted intervention to reduce low-value injury care

    BMC Health Serv Res 25 (1), 2025.

    DOI PUBMED
  • article Mésidor M, Sirois C, Guertin JR, Poirier P, Blais C, Talbot D

    Author’s reply: « The importance of properly specifying your target trial emulation: commentary on Mésidor et al. »

    J Clin Epidemiol 180 2025.

    DOI PUBMED
  • article Kouame JM, Guertin JR, Bautrant É and Levêque C, Siani C

    Modelling the cost effectiveness and budget impact of uterine botulinum toxin injections versus conventional treatment in severe dysmenorrhoea: A French perspective

    J Gynecol Obstet Hum Reprod 54 (4), 2025.

    DOI PUBMED
  • article Dupuis F, Guertin JR, Gagnon R, Larue S, Fredette MA, Hébert LJ, Desmeules F, Perreault K, Roy JS

    Is Group-Based Physiotherapy a Cost-Effective Intervention Compared to Usual One-on-One Physiotherapy Care in the Management of Musculoskeletal Disorders in Active Military Pers…

    J Orthop Sports Phys Ther 55 (4), 2025.

    DOI PUBMED
  • article Nguyen HM, Guertin JR, Reinharz D

    Perception of non-layperson advisory committee members on the application of a discrete choice experiment instrument to patients and advisory committee members: a qualitative study

    Int J Technol Assess Health Care 41 (1), 2025.

    DOI PUBMED
  • article Bénard E, Gatovo KE, Guertin JR

    Environmental considerations in health technology assessments performed by Canadian agencies

    Int J Technol Assess Health Care 41 (1), 2025.

    DOI PUBMED
  • article Delisle JS, Fournier D, Santerre K, Rochette S, Zawati MH, Dumont-Lagacé M, Turcotte S, Guertin JR, Vermette P, Tremblay JP, Parisotto M, Beauséjour C, Gélinas JF, Petropoulos L, Kekre N, Michaud S, Dieudé M

    Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

    Front Med (Lausanne) 12 2025.

    DOI PUBMED
  • article Gnanou S, Guertin JR, Tardif PA, Conombo B, Bérubé M, Yanchar N, Berthelot S, Gnanvi J, Moore L

    Cost-effectiveness of specialized trauma care: A systematic review

    J Health Serv Res Policy 31 (1), 2026.

    DOI PUBMED
  • article Lapointe J, Guillaumie L, Dionne A, Lalonde L, Lemieux J, Dorval M, Nabi H, Lemay M, Guénette L, Guertin JR, Mâsse B, Lauzier S

    A community pharmacy-based program to enhance adherence to adjuvant endocrine therapy among breast cancer survivors (PACHA): protocol for a pilot cluster-randomized controlled tr…

    Pilot Feasibility Stud 11 (1), 2025.

    DOI PUBMED
  • article Lafrance S, Budtz CR, Kinnerup MB, Desmeules F, Guertin JR, Madsen MN, Christiansen DH

    Economic evaluation of advanced practice physiotherapy models of care for upper extremity musculoskeletal disorders In Denmark: a registry-based cohort study

    Eur J Health Econ 2025.

    DOI PUBMED
  • article Gagnon M, Guertin JR, Sirois C, Simard M, Cossette B, Gagnon ME

    Cost trends of potentially inappropriate medications among older adults between 2012 and 2021 in Quebec, Canada: a population-based repeated cross-sectional study

    BMC Geriatr 25 (1), 2025.

    DOI PUBMED
  • article Delisle JS, Fournier D, Santerre K, Rochette S, Zawati MH, Dumont-Lagacé M, Turcotte S, Guertin JR, Vermette P, Tremblay JP, Parisotto M, Beauséjour C, Gélinas JF, Petropoulos L, Kekre N, Michaud S, Dieudé M

    Correction: Harnessing the promises of cell therapy, gene therapy, and regenerative medicine in Québec, Canada

    Front Med (Lausanne) 12 2025.

    DOI PUBMED